Klichinsky Michael 4
4 · Carisma Therapeutics Inc. · Filed Jan 30, 2025
Insider Transaction Report
Form 4
Klichinsky Michael
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-28+221,000→ 221,000 totalExercise: $0.50Exp: 2035-01-28→ Common Stock (221,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest over four years in equal monthly installments, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.